Caplin Point Laboratories Ltd approves Q2 FY27 results, with consolidated revenue of ₹629.8 crore and net profit of ₹182.4 crore
- Revenue rose 17.9% year on year and 3.2% sequentially.
- EBITDA margin was 38.7%; net profit increased 13.8% year on year and 1.8% sequentially.
- Board approved unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026, along with the limited review report; no exceptional items were reported.
